Work

Abstract 3096: The RXR agonist MSU-42011 and the MEK inhibitor selumetinib reduce tumor burden by decreasing pERK levels and modulating immune cell populations within the NF1 tumor microenvironment

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-3096

Authors: Pei-Yu Peggy Hung, Jessica A. Moerland, Karen T. Liby

Institutions: Michigan State University, Indiana University School of Medicine

Language: English

Topic: Neurofibromatosis and Schwannoma Cases

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409633386

Cites:

Cited by:

Related to: 10